Skip to main content

Table 4 Tumor retention in patients imaged with 18F-FAU

From: Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: 18F-FAU, 18F-FMAU, and 18F-FLT

Patient no.

Tumor SUVmean

Tracer flux into tumor (cc/min)

Baseline

Post-treatment

% Change

Baseline

Post-Treatment

% Change

11

1.03

1.06

2.9

No Dynamic Images

12

1.05

0.87

−17.1

0.0032

0.0019

−40.6

13

2.57

2.15

−16.3

0.0058

0.0055

−5.2

14

1.82

2.17

19.2

0.0108

0.0158

46.3

15

3.47

2.07

−40.3

0.0039

0.0029

−25.6